0 Yorumlar
0 hisse senetleri
350 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Exosome Therapeutics Market: Size, Share, and Growth Forecast 2025 –2032According to the latest report published by Data Bridge Market Research, the Exosome Therapeutics Market CAGR Value Data Bridge Market Research analyses that the exosome therapeutics market, which was USD 550.58 thousand in 2022, would rise to USD 1,986.86 thousand by 2030 and is expected to undergo a CAGR of 17.40% during the forecast period 2023 to 2030. The Exosome...0 Yorumlar 0 hisse senetleri 289 Views 0 önizleme
-
Exosome Therapeutics Market: Trends and Growth Opportunities 2025 –2032Detailed Analysis of Executive Summary Exosome Therapeutics Market Size and Share CAGR Value Data Bridge Market Research analyses that the exosome therapeutics market, which was USD 550.58 thousand in 2022, would rise to USD 1,986.86 thousand by 2030 and is expected to undergo a CAGR of 17.40% during the forecast period 2023 to 2030. The Exosome Therapeutics report makes available the...0 Yorumlar 0 hisse senetleri 737 Views 0 önizleme
-
Gout Therapeutics Market: Insights and Competitive Analysis 2025 –2032Gout Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Gout Therapeutics Market CAGR Value Data Bridge Market Research analyses a growth rate in the gout therapeutics market in the forecast period 2023-2030. The expected CAGR of gout therapeutics market is tend to be around 8.9% in the mentioned forecast period. The market was...0 Yorumlar 0 hisse senetleri 256 Views 0 önizleme
-
Gout Therapeutics Market: Trends and Growth Opportunities 2025 –2032Executive Summary Gout Therapeutics Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses a growth rate in the gout therapeutics market in the forecast period 2023-2030. The expected CAGR of gout therapeutics market is tend to be around 8.9% in the mentioned forecast period. The market was valued at USD 2.40 billion in 2022, and it would grow upto USD...0 Yorumlar 0 hisse senetleri 523 Views 0 önizleme
-
Lung Transplant Therapeutics Market Growth and Future TrendsLung Transplant Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Transplant Therapeutics Market CAGR Value The global lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the...0 Yorumlar 0 hisse senetleri 464 Views 0 önizleme
-
Non-Radiographic Axial Spondyloarthritis Therapeutics Market Research Report: Industry Analysis and Future Prospects"According to the latest report published by Data Bridge Market Research, the Non-Radiographic Axial Spondyloarthritis Therapeutics Market The global non-radiographic axial spondyloarthritis therapeutics market size was valued at USD 5.37 billion in 2024 and is expected to reach USD 7.99 billion by 2032, at a CAGR of 5.1% during the forecast period Market...0 Yorumlar 0 hisse senetleri 188 Views 0 önizleme
-
Probiotic-Based Vaginal Therapeutics Market Demand Analysis & Strategic Business OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Probiotic-Based Vaginal Therapeutics Market The global probiotic-based vaginal therapeutics market size was valued at USD 654.23 million in 2024 and is expected to reach USD 1,194.88 million by 2032, at a CAGR of 7.82% during the forecast period This world-wide Probiotic-Based Vaginal Therapeutics Market...0 Yorumlar 0 hisse senetleri 121 Views 0 önizleme
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Dynamics: Trends and Forecast 2025 –2032Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Selective Estrogen Receptor Degraders (SERD) Therapeutics Market CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to...0 Yorumlar 0 hisse senetleri 444 Views 0 önizleme
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Insights, Key Players, and Growth Analysis 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Research: Share and Size Intelligence CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period This...0 Yorumlar 0 hisse senetleri 993 Views 0 önizleme
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 Yorumlar 0 hisse senetleri 309 Views 0 önizleme
-
(R)-Nipecotic Acid Ethyl Ester Market Size & Forecast 2034 | Chiral Pharmaceutical Intermediate for CNS Drugs, GABA Uptake Inhibitors & Neurological TherapeuticsGlobal (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period. (R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...0 Yorumlar 0 hisse senetleri 296 Views 0 önizleme
-
Amnestic Disorders Therapeutics Market Size, Demand, Growth and Competitive AnalysisExecutive Summary Amnestic Disorders Therapeutics Market Size, Share, and Competitive Landscape Data Bridge Market Research analyses that the global amnestic disorders therapeutics market which was USD 3,372 million in 2022, would rocket up to USD 6,521 million by 2030, and is expected to undergo a CAGR of 4.20 % during the forecast period. An exceptional Amnestic Disorders Therapeutics...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Anti-Emetic Drugs Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030 Global market research...0 Yorumlar 0 hisse senetleri 200 Views 0 önizleme
-
Antihistamine Drugs Market Expands with Rising Allergy Treatment DemandAccording to the latest report published by Data Bridge Market Research, the Antihistamine Drugs Market CAGR Value Antihistamine Drugs Market report, businesses can acquire details about market drivers and market restraints which help them to guess about reducing or growing the production of particular product. It also arranges for top to bottom examination of the market for...0 Yorumlar 0 hisse senetleri 426 Views 0 önizleme
-
Antihistamine Drugs Market Grows Amid Rising Allergy and Respiratory ConditionsExecutive Summary: Antihistamine Drugs Market Size and Share by Application & Industry The global antihistamine drugs market size was valued at USD 305.85 million in 2024 and is expected to reach USD 620.71 million by 2032, at a CAGR of 9.25% during the forecast period For the growth of business, Antihistamine Drugs Market analysis report...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Antisense and RNAi Therapeutics Market Growth Fueled by Genetic Medicine InnovationsThe Antisense and RNAi Therapeutics Market is experiencing rapid growth due to increasing advancements in genetic medicine, rising prevalence of chronic diseases, and growing investments in biotechnology research. Antisense and RNA interference therapeutics are transforming the pharmaceutical industry by enabling targeted gene silencing and precise treatment approaches for complex diseases....0 Yorumlar 0 hisse senetleri 434 Views 0 önizleme
-
Antisense and RNAi Therapeutics Market Size Projected to Reach USD 9.65 Billion by 2032“According to a new report published by Introspective Market Research, Antisense and RNAi Therapeutics Market by Product Type, Application, and End User, The Global Antisense and RNAi Therapeutics Market Size Was Valued at USD 4.4 Billion in 2023 and is Projected to Reach USD 9.65 Billion by 2032, Growing at a CAGR of 18.2% from 2024 to 2032.” The Antisense and RNAi Therapeutics...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Arthralgia Drugs Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Arthralgia Drugs Market Data Bridge Market Research analyses that the arthralgia drugs market was valued at USD 64.56 billion in 2021 and is expected to reach USD 89.04 billion by 2029, registering a CAGR of 4.10% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market...0 Yorumlar 0 hisse senetleri 167 Views 0 önizleme
-
Asia Pacific Cancer Therapeutics Market Outlook Indicates USD 96,537.58 Million by 2031The Asia Pacific cancer therapeutics market is experiencing remarkable growth, driven by the rising cancer burden, increasing adoption of targeted therapies and immunotherapies, expanding healthcare infrastructure, and growing investments in precision oncology. According to Business Market Insights, the market was valued at USD 36,572.60 million in 2024 and is expected to...0 Yorumlar 0 hisse senetleri 238 Views 0 önizleme
Arama Sonuçları